Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1

Status

Completed 6

Sponsor Class

OTHER 8INDUSTRY 6

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Dermatologic 6

Conditions

Keratosis, Actinic 6Carcinoma, Basal Cell 4Bowen's Disease 2Warts 1Uterine Cervical Dysplasia 1Keratosis 1Carcinoma, Squamous Cell 1Carcinoma 1

Interventions

3-ingenyl angelate 33Imiquimod 18Aminolevulinic Acid 16Gels 10Diclofenac 10Photochemotherapy 7methyl 5-aminolevulinate 6Fluorouracil 6Solutions 5LEO 43204 5BF-200 ALA 5tirbanibulin 4Ointments 4Cryotherapy 3SR-T100 2potassium dobesilate 1green tea extract polyphenone E 1beta-solamarine 1afamelanotide 1Therapies, Investigational 1Therapeutics 1Petrolatum 1Excipients 1Drugs, Generic 1Cryosurgery 1Control Groups 1AVX001 15-fluorouracil, salicylic acid drug combination 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Keratosis, Actinic × methyl 5-aminolevulinate × Clear all
NCT00472459 2025-04-18

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Galderma R&D

Phase 3 Completed
82 enrolled 20 charts
Dermatologic

Bowen's Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Warts, Keratosis, Actinic

NCT05725213 2024-02-23

ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis

Galderma Laboratorium GmbH

Completed
224 enrolled
Dermatologic

Keratosis, Actinic

NCT01475071 2021-02-18

CoMet

Galderma R&D

Phase 3 Completed
100 enrolled 8 charts
Dermatologic

Keratosis, Actinic

NCT03511326 2021-02-18

SESAME 2

Galderma R&D

Phase 4 Completed
50 enrolled 9 charts
Dermatologic

Keratosis, Actinic

NCT02674048 2021-02-17

SESAME

Galderma R&D

Completed
406 enrolled
Dermatologic

Keratosis, Actinic

NCT02799069 2017-04-28

Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy

Biofrontera Bioscience GmbH

Phase 3 Completed
571 enrolled 46 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡